Everyone’s a winner: UCB bids $2.1B for Ra Pharma, adds to MG pipeline Oct. 11, 2019 By Cormac Sheridan No Comments DUBLIN – Shares in Ra Pharmaceuticals Inc. doubled Thursday as UCB SA made a $48-per-share bid that values the company at about $2.5 billion, or about $2.1 billion net of Ra’s cash.Read More